DANIPHARM A/S: Financial statements 2017
CVR: 12335040
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
DANIPHARM A/S (CVR 12335040) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 93,581,442 and a net result of DKK 11,319,150 compared with DKK 15,240,178 the year before. That is an increase of 9.9% compared with the year before. The profit margin was 12.1%. Equity in the 2017 report amounted to DKK 50,601,119. The solvency ratio was 78.1%. The company had 26 employees in the financial year.
- Revenue
- DKK 93,581,442
- Gross Profit
- DKK 37,027,664
- Profit/Loss
- DKK 11,319,150
- Equity
- DKK 50,601,119
- Total Assets
- DKK 64,826,621
- Employees
- 26
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 93.6 mio. | 37 mio. | 11.3 mio. | 50.6 mio. | 26 |
| 2016 | 85.2 mio. | 40.9 mio. | 15.2 mio. | 41.8 mio. | 22 |
| 2015 | 85.1 mio. | 34.9 mio. | 11.3 mio. | 26.5 mio. | 23 |
| 2014 | 90.1 mio. | 30.9 mio. | 8.9 mio. | 15.3 mio. | 23 |
| 2013 | 84.8 mio. | 21.9 mio. | 232 t. | 6.4 mio. | 21 |
Official annual report
Keep an eye on DANIPHARM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout DANIPHARM A/S
DANIPHARM A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1988. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Niels Ulrik Heine (chair), Helle Rørvig and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 37,586,751 and a net result of DKK 13,717,304 compared with DKK 5,113,647 the year before. Equity in the 2025 report amounted to DKK 60,280,949.